Naito Masanori, Yamazaki Takeshi, Tsutsumi Ryouhei, Higashi Hideaki, Onoe Kazunori, Yamazaki Shiho, Azuma Takeshi, Hatakeyama Masanori
Division of Molecular Oncology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
Gastroenterology. 2006 Apr;130(4):1181-90. doi: 10.1053/j.gastro.2005.12.038.
BACKGROUND & AIMS: Helicobacter pylori CagA-positive strain is associated with gastric adenocarcinoma. CagA is delivered into gastric epithelial cells, where it undergoes tyrosine phosphorylation at the EPIYA sites by Src family kinases (SFKs). Owing to homologous recombination within the 3'-region of the cagA gene, 4 distinct EPIYA sites, each of which is defined by surrounding sequences, are variably assembled in both number and order among CagA proteins from different clinical H pylori isolates. Tyrosine-phosphorylated CagA specifically binds and deregulates SHP-2 via the Western CagA-specific EPIYA-C or East Asian CagA-specific EPIYA-D site, and C-terminal Src kinase (Csk) via the EPIYA-A or EPIYA-B site. Here we investigated the influence of EPIYA-repeat polymorphism on the CagA activity.
A series of EPIYA-repeat variants of CagA were expressed in AGS gastric epithelial cells and the ability of individual CagA to bind SHP-2 or Csk was determined by the sequential immunoprecipitation and immunoblotting method.
CagA proteins carrying multiple EPIYA-C or EPIYA-D sites bound and deregulated SHP-2 more strongly than those having a single EPIYA-C or EPIYA-D. Furthermore, the ability of CagA to bind Csk was correlated with the number of EPIYA-A and EPIYA-B sites. Because Csk inhibits SFK, CagA with greater Csk-binding activity more strongly inhibited Src-dependent CagA phosphorylation and more effectively attenuated induction of cell elongation caused by CagA-SHP-2 interaction.
EPIYA-repeat polymorphism of CagA greatly influences the magnitude and duration of phosphorylation-dependent CagA activity, which may determine the potential of individual CagA as a bacterial virulence factor that directs gastric carcinogenesis.
幽门螺杆菌CagA阳性菌株与胃腺癌相关。CagA被递送至胃上皮细胞,在细胞内它通过Src家族激酶(SFKs)在EPIYA位点发生酪氨酸磷酸化。由于cagA基因3'区域内的同源重组,4个不同的EPIYA位点,每个位点由周围序列定义,在来自不同临床幽门螺杆菌分离株的CagA蛋白中,其数量和顺序可变地组装。酪氨酸磷酸化的CagA通过Western CagA特异性EPIYA - C或东亚CagA特异性EPIYA - D位点特异性结合并使SHP - 2失调,通过EPIYA - A或EPIYA - B位点与C末端Src激酶(Csk)结合。在此,我们研究了EPIYA重复多态性对CagA活性的影响。
一系列CagA的EPIYA重复变体在AGS胃上皮细胞中表达,通过顺序免疫沉淀和免疫印迹法测定单个CagA结合SHP - 2或Csk的能力。
携带多个EPIYA - C或EPIYA - D位点的CagA蛋白比具有单个EPIYA - C或EPIYA - D位点的蛋白更强烈地结合并使SHP - 2失调。此外,CagA结合Csk的能力与EPIYA - A和EPIYA - B位点的数量相关。因为Csk抑制SFK,具有更强Csk结合活性的CagA更强烈地抑制Src依赖性CagA磷酸化,并更有效地减弱由CagA - SHP - 2相互作用引起的细胞伸长诱导。
CagA的EPIYA重复多态性极大地影响磷酸化依赖性CagA活性的幅度和持续时间,这可能决定个体CagA作为指导胃癌发生的细菌毒力因子的潜力。